According to the World Health Organization, there were 39.9 million people living with HIV worldwide by the end of 2023.
Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...